If Trouble Is Brewing for Banks, Here's Where...

Despite a rough past week for the healthcare sector, pharmaceuticals and biotech stocks have outperformed the S&P 500 this year. Investors have gotten excited over cancer treatment breakthroughs for Moderna, Merck and Revolution Medicines—plus regulatory shakeups at the FDA. But ...  Show more

On this week’s episode of WSJ’s Take On the Week, host Miriam Gottfried and guest host Aaron Back, editor of WSJ’s Heard on the Street, preview the upcoming employment and inflation releases in advance of the Federal Open Market Committee’s September policy meeting. They analyze ...  Show more

For YMB listeners, here’s a special presentation of WSJ’s Take On the Week: Co-hosts Gunjan Banerji, lead writer for Live Markets, and Telis Demos, Heard on the Street’s banking and money columnist, cut through the noise and dive into markets, the economy, and finance—the big tra ...  Show more

 On this edition of Wall Street Week, Mona Mahajan, Edward Jones Sr. Investment Strategist and Greg Peters, PGIM Co-CIO of Fixed Income discuss how bank concerns have rattled Wall Street. Sam Palmisano, and Former US Treasury Secretary Lawrence H. Summers warns of the danger of c ...  Show more

 On this edition of Wall Street Week, Saira Malik, Nuveen CIO & Kristina Hooper, Invesco Chief Global Market Strategist on the week that was in the markets. Glenn Hubbard, Columbia School of Business Dean Emeritus and Professor of Finance and Economics takes us through the bankin ...  Show more

 On this edition of Wall Street Week, Sonal Desai, Franklin Templeton Fixed Income CIO & Dennis DeBusschere, 22V Research President, Partner and Chief Market Strategist. Former Treasury Secretary, Larry Summers, Former Fed Board Member, Dan Tarullo And Stephanie Flanders, Bloombe ...  Show more